Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
lungcanc
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
PASSION Results Support Further Study of Camrelizumab Plus Apatinib in SCLC
IASLC 2019 Mesothelioma Meeting Offers Innovative Approach for Rapid Learning
lungcanc
IASLC Targeted Therapies of Lung Cancer Meeting Draws Record Abstract Submissions,...
lungcanc
IASLC SCLC Meeting Program, Faculty to Reflect the Field’s Pivotal, Recent...
lungcanc
The IASLC’s Spotlight on Screening
lungcanc
Scientific Highlights from the IASLC Latin America Conference on Lung Cancer
lungcanc
Inaugural LATAM Awards
lungcanc
Highlights from the NCI Post-Treatment Surveillance Workshop
lungcanc
Top Science in Lung Cancer Featured at WCLC 2018
lungcanc
WCLC Plenary Symposia to Include Practice-Changing Research Presentations
lungcanc
The Long Road Home
lungcanc
1
2
3
...
6
Page 2 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
